Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of September 2022, with the report dated September 6, 2022. The filing documents the results of a Special General Meeting of Shareholders convened on September 1, 2022.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events rather than financial performance.
Material Changes
There are no material financial changes reported in this document. The primary event is the successful conclusion of the Special General Meeting, where a quorum was present and shareholders approved all agenda items described in the notice and proxy statement filed on July 27, 2022.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It serves solely to confirm shareholder approval of previously disclosed agenda items and to incorporate the report by reference into the Company's Registration Statements on Form F-3 and Form S-8.
Investor Verification Checklist
- Verify the specific agenda items approved by shareholders by reviewing the notice and proxy statement filed on July 27, 2022 (Exhibit 99.1).
- Confirm the incorporation of this report into the Company's active Registration Statements (File Nos. 333-267272, 333-262620, and 333-264578).
- Review subsequent filings for financial data, as this Form 6-K contains no financial metrics.